Veracyte, Inc. operates as a diagnostics company worldwide.
$24.16+0.67%
报价 2026-11-06
市值
$1.94B
EV
$3.61B
PE (TTM)
33.7x
预期 PE (FY2026)
12.6x
52 周区间距高点 -60.1%
$24.00$60.49
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
爆发潜力
2026-11-07不在筛选范围：industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| VCYTVeracyte, Inc. | $1.94B | +0.7% | +14.3% | 72.1% | 33.7x | 27.8x | 23.4x | |
| KNSAKiniksa Pharmaceuticals, Ltd. | $7.37B | +6.2% | – | 54.3% | 64.5x | 49.8x | 36.8x | |
| SRRKScholar Rock Holding Corporation | $5.72B | +3.2% | +3100.0% | 0% | – | – | – | |
| ADPTAdaptive Biotechnologies Corporation | $4.47B | +4.3% | +7.6% | 75.3% | – | – | – | |
| LEGNLegend Biotech Corporation | $4.33B | +3.8% | +39.4% | 55% | – | – | – | |
| TARSTarsus Pharmaceuticals, Inc. | $3.38B | +1.6% | +56.4% | 90.6% | – | – | 63.5x | |
| IRONDisc Medicine, Inc. | $3.03B | +0.6% | -47.5% | 0% | – | – | – | |
| IDYAIDEAYA Biosciences, Inc. | $3.01B | +1.9% | -84.0% | 99.5% | – | – | – | |
| ZLABZai Lab Limited | $2.87B | +12.7% | – | 56.5% | – | – | – | |
| 同行中位数 | – | – | +23.5% | 55.7% | 64.5x | 49.8x | 50.1x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。